Filter byLast updated dateSelectAfterBeforeFrom - ToDateEnd DateThis weekThis monthLast weekLast monthCategoryHumanCorporateVeterinaryHerbalTopicMedicinesCOVID-19PharmacovigilanceVaccinesReferralsPaediatricsRare diseasesRegulatory and procedural guidanceClinical trialsAdvanced therapiesData on medicinesCompliance and inspectionsInnovationResearch and developmentMedicine shortagesBiosimilarsSMEAntimicrobial resistanceGovernanceBrexitQuality of medicinesGeneric and hybrid medicinesCorporateEarly accessFeesProduct informationMedicines for use outside the EUMedical devicesScientific adviceMaximum residue limitMpoxBiologicalsScientific guidelinesVeterinary limited marketsCompassionate useCareersMedication errorParallel distributionProcurementDiseases areaViral diseasesCancerImmune-system diseasesDiabetesNeurodegenerative diseasesCardiovascular diseasesHIV and AIDSResponsible bodyCHMPCVMPPRACManagement BoardCOMPPDCOCMDhHMPCCATPatient safetyYesLeave this field blankFiltersResults (3750) Sort byLast update date (new to old)Last update date (old to new)A-ZZ-ALeave this field blankMeeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023 22 May 2023 NewsHumanPharmacovigilanceReferralsFluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects 22 May 2023 NewsHumanPharmacovigilanceReferralsMeeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 2023 22 May 2023 NewsVeterinaryMaximum residue limitMedicinesGuidance for industry to prevent and mitigate medicine shortages 17 May 2023 NewsHumanMedicine shortagesEMA business hours over Ascension Day holidays, 18 and 19 May 16 May 2023 NewsHumanCorporateEMA annual report 2022 published 15 May 2023 NewsHumanVeterinaryCorporateEMA and European medicines regulatory network lift COVID-19 business continuity status 10 May 2023 NewsHumanCOVID-19Statement from Emer Cooke on the end of the COVID-19 public health emergency 8 May 2023 NewsHumanCOVID-19EMA business hours on Europe Day, Tuesday 9 May 5 May 2023 NewsHumanCorporateReview of transparency rules for the EU Clinical Trials Information System (CTIS) 3 May 2023 NewsHumanClinical trialsPrevious222324252627282930Next
Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC) 10 - 12 May 2023 22 May 2023 NewsHumanPharmacovigilanceReferrals
Fluoroquinolone antibiotics: reminder of measures to reduce the risk of long-lasting, disabling and potentially irreversible side effects 22 May 2023 NewsHumanPharmacovigilanceReferrals
Meeting highlights from the Committee for Veterinary Medicinal Products (CVMP) 15-16 May 2023 22 May 2023 NewsVeterinaryMaximum residue limitMedicines
Guidance for industry to prevent and mitigate medicine shortages 17 May 2023 NewsHumanMedicine shortages
EMA and European medicines regulatory network lift COVID-19 business continuity status 10 May 2023 NewsHumanCOVID-19
Statement from Emer Cooke on the end of the COVID-19 public health emergency 8 May 2023 NewsHumanCOVID-19
Review of transparency rules for the EU Clinical Trials Information System (CTIS) 3 May 2023 NewsHumanClinical trials